While the cryptocurrency market is on a volatile course, the leading cryptocurrency Bitcoin has turned its direction downwards again after rising northwards. In this environment of uncertainty, Binance announced that it will list a new token on the futures markets. This development led to sharp fluctuations in the price of the BIO token.

Binance to Launch Perpetual Contracts for BIO with 75x Leverage!
While the market is struggling to find a clear direction, cryptocurrency exchanges continue to take new steps. Binance, one of the largest exchanges in the world, announced that it will list its Bio Protocol (BIO) token on Binance Earn, Buy Crypto with One Click, Instant Exchange, Leveraged Tokens, Binance Launchpool, and Binance Futures platforms. BIO’s 1-75x leveraged reverse perpetual contract is scheduled to launch on January 3, 2025 at 15:15 UTC. Binance announced this development as follows:

"Dear Binance users, BIO Protocol (BIO) will be added to Binance Simple Earn, 'Buy Crypto', Binance Convert, Binance Margin, Binance Auto-Invest, and Binance Futures on the dates below."

Following this announcement, the listing price of the BIO token reached $1,477, but the token’s price has since declined. At the time of writing, BIO is trading at $0.66, marking a drop of approximately 17% from the token’s starting price. Furthermore, the token’s trading volume has also been flat, suggesting that investors are not showing significant interest in BIO at the moment.

BIO's Listing Schedule and Other Details

  • 03.01.2025, 13:00 CET: BIO will be listed on Binance Simple Earn and will be available for subscription.

  • 06.01.2025, 13:00 GMT: Users will be able to purchase BIO via Binance Auto Trading.

  • Buy & Sell Crypto: Users will be able to purchase BIO tokens with VISA, MasterCard, Google Pay, and Apple Pay. BIO will be available for zero-fee trading against BTC, USDT, and other tokens within an hour of listing on Binance Spot.

  • Binance Margin: On 03.01.2025, at 15:00 CET, the BIO token will be listed on Binance Margin as a borrowable asset for Cross and Isolated Margin, along with the BIO/USDT pair.

These steps increase BIO’s visibility in the market and offer new opportunities to investors.